Cyrus Chowdhury, CEO, CBPartners

Mr. Chowdhury’s career has focused on global strategic issues across six continents, split evenly between emerging markets (BRIC-MT and through the top 72 emerging markets) and developed markets (EU-5, Japan, Australia and Canada). His achievements include successful assignments in pharmaceutical and medical technology commercial planning, price integrity, payer partnerships, innovative access schemes, patient access programs, customer value approach, and portfolio-level global market access strategies. With GENZYME, he developed the company’s first parallel trade pricing defense strategy. While with CAMBRIDGE PHARMA CONSULTANCY (now part of IMS), Mr. Chowdhury played an integral role in launching the firm’s Greater China market access consulting operations, spending much of his time focusing on pan-Asian issues. Additionally, Mr. Chowdhury served as a research specialist with the London School of Economics, WHO and European Observatory on Health for Central and Eastern Europe.